Cilostazol
NDC Package 0615-6513-39

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Cilostazol is used to improve the symptoms of a certain blood flow problem in the legs (intermittent claudication). Marketed by Ncs Healthcare Of Ky, Inc Dba Vangard Labs, this product is identified by NDC 0615-6513 and is authorized under FDA application ANDA077027.

Identification & Billing

NDC Package Code
0615-6513-39
Package Description
30 TABLET in 1 BLISTER PACK
Product Code
0615-6513
11-Digit Billing Format
00615651339

Clinical Specifications

Proprietary Name
Cilostazol
Dosage Form
-
Usage Information
Cilostazol is used to improve the symptoms of a certain blood flow problem in the legs (intermittent claudication). Cilostazol can decrease the muscle pain/cramps that occur during exercise/walking. Claudication pain is caused by too little oxygen getting to the muscles. Cilostazol can increase blood flow and the amount of oxygen that gets to the muscles. Cilostazol is an antiplatelet drug and a vasodilator. It works by stopping blood cells called platelets from sticking together and prevents them from forming harmful clots. It also widens blood vessels in the legs. Cilostazol helps the blood to move more easily and keeps blood flowing smoothly in your body.

Regulatory & Marketing

Labeler Name
Ncs Healthcare Of Ky, Inc Dba Vangard Labs
FDA Application #
ANDA077027
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-04-2009
End Marketing Date
04-26-2012
Listing Expiration
04-26-2012
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0615-6513-39 identifies a specific commercial package of 30 tablet in 1 blister pack of Cilostazol, labeled by Ncs Healthcare Of Ky, Inc Dba Vangard Labs. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ncs Healthcare Of Ky, Inc Dba Vangard Labs on November 04, 2009. The current certification is valid through April 26, 2012.

What are the primary indications for this medication?

Cilostazol is used to improve the symptoms of a certain blood flow problem in the legs (intermittent claudication). Cilostazol can decrease the muscle pain/cramps that occur during exercise/walking. Claudication pain is caused by too little oxygen getting to the muscles. Cilostazol can increase blood flow and the amount of oxygen that gets to the muscles. Cilostazol is an antiplatelet drug and a vasodilator. It works by stopping blood cells called platelets from sticking together and prevents them from forming harmful clots. It also widens blood vessels in the legs. Cilostazol helps the blood to move more easily and keeps blood flowing smoothly in your body.

How is this Ncs Healthcare Of Ky, Inc Dba Vangard Labs product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00615651339. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0615-6513-39
11-Digit CMS (5-4-2)
00615-6513-39

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.